MaxCyte Market Cap

MaxCyte has a market cap or net worth of $412.35 million as of April 23, 2024. Its market cap has decreased by -25.10% in one year.

Market Cap

412.35M

Enterprise Value

262.81M

1-Year Change

-25.10%

Ranking

#3079

Market Cap Chart

Since the IPO on July 30, 2021, MaxCyte's market cap has decreased from $897.06M to $412.35M, a decrease of -54.03%. That is a compound annual growth rate of -24.76%.

Market Cap History

Date	Market Cap	% Change
Apr 22, 2024	412.30M	0.24%
Apr 19, 2024	411.30M	1.81%
Apr 18, 2024	404.00M	-1.54%
Apr 17, 2024	410.30M	-1.25%
Apr 16, 2024	415.50M	2.85%
Apr 15, 2024	404.00M	-3.00%
Apr 12, 2024	416.50M	-3.16%
Apr 11, 2024	430.10M	0.99%
Apr 10, 2024	425.90M	-1.43%
Apr 9, 2024	432.10M	0.23%
Apr 8, 2024	431.10M	-0.23%
Apr 5, 2024	432.10M	0.72%
Apr 4, 2024	429.00M	-3.05%
Apr 3, 2024	442.50M	3.39%
Apr 2, 2024	428.00M	-1.90%
Apr 1, 2024	436.30M	-
Mar 28, 2024	436.30M	-3.00%
Mar 27, 2024	449.80M	-0.46%
Mar 26, 2024	451.90M	-0.24%
Mar 25, 2024	453.00M	-1.56%
Mar 22, 2024	460.20M	-2.00%
Mar 21, 2024	469.60M	0.21%
Mar 20, 2024	468.60M	0.90%
Mar 19, 2024	464.40M	6.96%
Mar 18, 2024	434.20M	-3.25%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
biote	413.28M
Voyager Therapeutics	413.23M
Pacific Biosciences of California	413.05M
IGM Biosciences	411.45M
Tourmaline Bio	410.34M
LENZ Therapeutics	405.22M
Avid Bioservices	404.73M
Humacyte	401.91M

Market Cap Rankings